MassMutual Private Wealth & Trust’s Soleno Therapeutics SLNO Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3	Closed	-$100	–	2487
2026 Q1	$100	Buy	+3	New	+$118	﹤0.01%	2357

MassMutual Private Wealth & Trust's SLNO Position: Q2 2026 in Review

MassMutual Private Wealth & Trust sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 3 shares — an estimated $100 sold.

MassMutual Private Wealth & Trust first reported a position in SLNO in Q1 2026 and held it in 1 quarter. The position peaked at $100 in Q1 2026. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

MassMutual Private Wealth & Trust reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
MassMutual Private Wealth & Trust sold 3 Soleno Therapeutics shares in Q2 2026, an estimated $100.
MassMutual Private Wealth & Trust first reported a position in Soleno Therapeutics in Q1 2026 and held it in 1 quarter.
MassMutual Private Wealth & Trust's Soleno Therapeutics position peaked at $100 in Q1 2026.
0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.